Although the neoplastic significance of the chromosome changes widespread in Hodgkin's disease (HD) remains obscure, a distinct cytogenetic picture has emerged combining aneuploidy with structural ...
PerkinElmer Inc. reports it has purchased the assets of Spectral Genomics Inc., a Houston-based company focused on molecular karyotyping technology used to evaluate chromosomal abnormalities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback